By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company NewcelX Ltd.

NewcelX Ltd. (NCEL)

NASDAQ Fundamentals in USD
Price unavailable
Market Cap
P/E Ratio (TTM)
Forward Dividend Yield
52 Week Range

NCEL Stock Price Chart

Explore NewcelX Ltd. interactive price chart. Choose custom timeframes to analyze NCEL price movements and trends.

NCEL Company Profile

Discover essential business fundamentals and corporate details for NewcelX Ltd. (NCEL) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

24 Oct 2025

Employees

11.00

CEO

Ronen Twito

Description

NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.

NCEL Financial Timeline

Browse a chronological timeline of NewcelX Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

NCEL Stock Performance

Access detailed NCEL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run